Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

Clinical trial NCT01583426 · COMPLETED

Trial details

NCT number: NCT01583426
Sponsor: GBG Forschungs GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tubular Breast Cancer Stage II Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer Tubular Breast Cancer Stage III HER-2 Positive Breast Cancer Inflammatory Breast Cancer Stage IV Inflammatory Breast Cancer

Start date: 2012-07-01
Primary completion: 2018-12-01
Enrollment: 1229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.